1. Home
  2. VCIG vs NEPH Comparison

VCIG vs NEPH Comparison

Compare VCIG & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCIG
  • NEPH
  • Stock Information
  • Founded
  • VCIG 2013
  • NEPH 1997
  • Country
  • VCIG Malaysia
  • NEPH United States
  • Employees
  • VCIG N/A
  • NEPH N/A
  • Industry
  • VCIG Diversified Commercial Services
  • NEPH Medical/Dental Instruments
  • Sector
  • VCIG Consumer Discretionary
  • NEPH Health Care
  • Exchange
  • VCIG Nasdaq
  • NEPH Nasdaq
  • Market Cap
  • VCIG 15.6M
  • NEPH 16.8M
  • IPO Year
  • VCIG 2023
  • NEPH 2004
  • Fundamental
  • Price
  • VCIG $4.18
  • NEPH $2.09
  • Analyst Decision
  • VCIG
  • NEPH Buy
  • Analyst Count
  • VCIG 0
  • NEPH 1
  • Target Price
  • VCIG N/A
  • NEPH $5.00
  • AVG Volume (30 Days)
  • VCIG 179.2K
  • NEPH 7.3K
  • Earning Date
  • VCIG 05-13-2025
  • NEPH 05-08-2025
  • Dividend Yield
  • VCIG 230.05%
  • NEPH N/A
  • EPS Growth
  • VCIG N/A
  • NEPH N/A
  • EPS
  • VCIG 54.73
  • NEPH 0.08
  • Revenue
  • VCIG $27,819,290.00
  • NEPH $15,517,000.00
  • Revenue This Year
  • VCIG N/A
  • NEPH $9.23
  • Revenue Next Year
  • VCIG N/A
  • NEPH $12.99
  • P/E Ratio
  • VCIG $0.09
  • NEPH $28.58
  • Revenue Growth
  • VCIG 36.99
  • NEPH 10.34
  • 52 Week Low
  • VCIG $2.30
  • NEPH $1.36
  • 52 Week High
  • VCIG $1,097.60
  • NEPH $2.55
  • Technical
  • Relative Strength Index (RSI)
  • VCIG 38.37
  • NEPH 57.94
  • Support Level
  • VCIG $5.01
  • NEPH $1.88
  • Resistance Level
  • VCIG $6.05
  • NEPH $2.23
  • Average True Range (ATR)
  • VCIG 0.72
  • NEPH 0.17
  • MACD
  • VCIG 0.30
  • NEPH 0.01
  • Stochastic Oscillator
  • VCIG 6.50
  • NEPH 69.23

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.

Share on Social Networks: